Loading...
•
Dec 31, 2023
Rockwell Medical Q4 2023 Earnings Report
Rockwell Medical achieved profitability on an Adjusted EBITDA basis and record net sales, gross profit, and gross margin for the full year.
Key Takeaways
Rockwell Medical reported achieving profitability on an adjusted EBITDA basis in Q4 2023, alongside record net sales, gross profit, and gross margin for the full year 2023. The company has focused on improving financial health, securing multi-year agreements, expanding geographically, and improving manufacturing efficiencies.
Achieved profitability on an adjusted EBITDA basis in Q4 2023.
Generated the highest revenue and gross profit to-date for the company in 2023.
Completed two acquisitions and renegotiated customer agreements.
Expanded geographic footprint both domestically and internationally.
Forward Guidance
Rockwell Medical projects net sales to grow in the mid-to-high single digits in 2025 and beyond. Rockwell Medical projects gross margin in 2025 to be approximately 20% and reaching above 25% in 2026 and beyond.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...